The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

List includes medications for diabetes, cancer, arthritis, and more ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

The U.S. government plans to lower Medicare costs for Botox by targeting its medical uses, marking a major shift in drug ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Medicare picks Botox and Trulicity for latest round of negotiations The Centers for ...

CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

CMS's third drug negotiation cycle under the IRA targets high-expenditure drugs, impacting Medicare Part B and D spending. The list includes drugs for cancer, HIV, and diabetes, with significant ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...